These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31411713)

  • 21. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
    Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
    Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of quality improvement on racial disparities in diabetes care.
    Sequist TD; Adams A; Zhang F; Ross-Degnan D; Ayanian JZ
    Arch Intern Med; 2006 Mar; 166(6):675-81. PubMed ID: 16567608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events.
    White HD; Stewart RAH; Dalby AJ; Stebbins A; Cannon CP; Budaj A; Linhart A; Pais P; Diaz R; Steg PG; Krug-Gourley S; Granger CB; Hochman JS; Koenig W; Harrington RA; Held C; Wallentin L;
    Am Heart J; 2020 Jul; 225():97-107. PubMed ID: 32480059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Pay-for-Performance Incentive Designs on Diabetes Care.
    Hsieh HM; Shin SJ; Tsai SL; Chiu HC
    Med Care; 2016 Dec; 54(12):1063-1069. PubMed ID: 27479599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.
    Barankay I; Reese PP; Putt ME; Russell LB; Loewenstein G; Pagnotti D; Yan J; Zhu J; McGilloway R; Brennan T; Finnerty D; Hoffer K; Chadha S; Volpp KG
    JAMA Netw Open; 2020 Oct; 3(10):e2019429. PubMed ID: 33034639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus monitoring and control among adults in Australian general practice: a national retrospective cohort study.
    Zheng M; Bernardo C; Stocks N; Hu P; Gonzalez-Chica D
    BMJ Open; 2023 Apr; 13(4):e069875. PubMed ID: 37185189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between attainment of incentivised primary care indicators and emergency hospital admissions among type 2 diabetes patients: a population-based historical cohort study.
    Gunn LH; McKay AJ; Molokhia M; Valabhji J; Molina G; Majeed A; Vamos EP
    J R Soc Med; 2021 Jun; 114(6):299-312. PubMed ID: 33821695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes care improvement in pharmacist- versus nurse-supported patient-centered medical homes.
    Min L; Cigolle CT; Bernstein SJ; Ward K; Moore TL; Ha J; Blaum CS
    Am J Manag Care; 2017 Nov; 23(11):e374-e381. PubMed ID: 29182358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes Outcome and Process Measures Among Patients Who Require Language Interpreter Services in Minnesota Primary Care Practices.
    Njeru JW; Boehm DH; Jacobson DJ; Guzman-Corrales LM; Fan C; Shimotsu S; Wieland ML
    J Community Health; 2017 Aug; 42(4):819-825. PubMed ID: 28229264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial.
    Kahkoska AR; Lawson MT; Crandell J; Driscoll KA; Kichler JC; Seid M; Maahs DM; Kosorok MR; Mayer-Davis EJ
    JAMA Netw Open; 2019 May; 2(5):e195137. PubMed ID: 31150087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral health disorders and adherence to measures of diabetes care quality.
    Leung GY; Zhang J; Lin WC; Clark RE
    Am J Manag Care; 2011 Feb; 17(2):144-50. PubMed ID: 21473663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality measure attainment in patients with type 2 diabetes mellitus.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
    Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Access to Specialty Care for Commercially Insured Youths With Type 1 and Type 2 Diabetes.
    March CA; Byerly AR; Siminerio L; Miller E; Rothenberger S; Libman I
    JAMA Netw Open; 2024 Apr; 7(4):e245656. PubMed ID: 38578636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
    Sattar NA; Ginsberg H; Ray K; Chapman MJ; Arca M; Averna M; Betteridge DJ; Bhatnagar D; Bilianou E; Carmena R; Ceška R; Corsini A; Erbel R; Flynn PD; Garcia-Moll X; Gumprecht J; Ishibashi S; Jambart S; Kastelein JJ; Maher V; da Silva PM; Masana L; Odawara M; Pedersen TR; Rotella CM; Salti I; Teramoto T; Tokgozoglu L; Toth PP; Valensi P; Vergès B
    Atheroscler Suppl; 2014 Jun; 15(1):1-15. PubMed ID: 24840509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trends in the level of control of patients with type 2 diabetes from 2010 to 2015].
    Herrero Gil AM; Pinillos Robles J; Sabio Repiso P; Martín Maldonado JL; Garzón González G; Gil de Miguel Á
    Aten Primaria; 2018 Oct; 50(8):459-466. PubMed ID: 28838742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.